+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Negative regulation of Gli1 and Gli2 activator function by Suppressor of fused through multiple mechanisms



Negative regulation of Gli1 and Gli2 activator function by Suppressor of fused through multiple mechanisms



Differentiation; Research in Biological Diversity 73(8): 397-405



During animal development, the Hedgehog (Hh) signal transduction pathway plays critical roles in cell fate determination and tissue patterning. In humans, aberrant Hh signaling has been linked to several genetic disorders and cancers. Binding of Hh to its receptor initiates a signaling cascade, which ultimately results in the activation of the Gli/Ci transcription factors. Suppressor of fused (Su(fu)) is a Gli/Ci-interacting protein, which acts as a negative regulator of Hh signaling in Drosophila and vertebrates. Su(fu) is also implicated as a tumor suppressor as its mutations have been found in medulloblastoma and prostate cancer. Su(fu) is thought to act by preventing the nuclear accumulation of Gli/Ci, however, mechanistic insight into its mode of action has remained elusive. We demonstrate here that Su(fu) prevents the nuclear accumulation of Gli1 and Gli2 through multiple mechanisms. While Su(fu) itself is not subject to CRM1-dependent regulation, Su(fu) sequesters Gli1 in the cytoplasm mostly through a mechanism that depends on the activity of the nuclear export protein CRM1. In contrast, CRM1-mediated export is not required for Su(fu) to sequester Gli2. Furthermore, we show that the N-terminus of Su(fu) is sufficient for Gli inactivation in the absence of cytoplasmic sequestration. Together, these observations reveal that Su(fu) regulates the activity of Gli1 and Gli2 through distinct cytoplasmic and nuclear mechanisms.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 012344424

Download citation: RISBibTeXText

PMID: 16316410

DOI: 10.1111/j.1432-0436.2005.00042.x


Related references

SCL/TAL1 interrupting locus derepresses GLI1 from the negative control of suppressor-of-fused in pancreatic cancer cell. Cancer Research 68(19): 7723-7729, 2008

Mouse Suppressor of fused is a negative regulator of Sonic hedgehog signaling and alters the subcellular distribution of Gli1. Current Biology 9(19): 1119-1122, 1999

Integrative genomic analyses on GLI1: positive regulation of GLI1 by Hedgehog-GLI, TGFbeta-Smads, and RTK-PI3K-AKT signals, and negative regulation of GLI1 by Notch-CSL-HES/HEY, and GPCR-Gs-PKA signals. International Journal of Oncology 35(1): 187-192, 2009

Suppressor of fused and Spop regulate the stability, processing and function of Gli2 and Gli3 full-length activators but not their repressors. Development 137(12): 2001-2009, 2010

Gli2 activator function in preosteoblasts is sufficient to mediate Ihh-dependent osteoblast differentiation, whereas the repressor function of Gli2 is dispensable for endochondral ossification. Developmental Dynamics 239(6): 1818-1826, 2010

Gli1 can rescue the in vivo function of Gli2. Development 128(24): 5161-5172, 2001

Function of zebrafish gli1 and gli2 in motor neuron development. Developmental Biology 235(1): 222, 2001

Overlapping binding sites for importin β1 and suppressor of fused (SuFu) on glioma-associated oncogene homologue 1 (Gli1) regulate its nuclear localization. Biochemical Journal 461(3): 469-476, 2014

Gli regulation by the opposing activities of fused and suppressor of fused. Nature Cell Biology 2(5): 310-312, 2000

Overlapping and distinct transcriptional regulator properties of the GLI1 and GLI2 oncogenes. Genomics 87(5): 616-632, 2006

Gli2, but not Gli1, is required for initial Shh signaling and ectopic activation of the Shh pathway. Development 129(20): 4753-4761, 2002

Suppressor of fused (Sufu) represses Gli1 transcription and nuclear accumulation, inhibits glioma cell proliferation, invasion and vasculogenic mimicry, improving glioma chemo-sensitivity and prognosis. Oncotarget 5(22): 11681-11694, 2014

Mouse Gli1 mutants are viable but have defects in SHH signaling in combination with a Gli2 mutation. Development 127(8): 1593-1605, 2000

Suppressor of cytokine signaling 3 negative regulation of signal transducer and activator of transcription 3 in platelet-derived growth factor-induced fibroblast migration. Journal of Dermatology 34(8): 523-530, 2007